Encysive Thelin Approval Could Come Days Ahead Of Gilead’s Ambrisentan

FDA’s regulatory timeline for reviewing the two pulmonary arterial hypertension medications may fall neck and neck.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet